Recurrence of primary aldosteronism after percutaneous ethanol injection
Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-03-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664612000290 |
_version_ | 1818364511173738496 |
---|---|
author | Fan-Chi Chang Kao-Lang Liu Kuo-How Huang Vin-Cent Wu Yen-Hung Lin Yung-Ming Chen Kwan-Dun Wu TAIPAI Study Group |
author_facet | Fan-Chi Chang Kao-Lang Liu Kuo-How Huang Vin-Cent Wu Yen-Hung Lin Yung-Ming Chen Kwan-Dun Wu TAIPAI Study Group |
author_sort | Fan-Chi Chang |
collection | DOAJ |
description | Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas. |
first_indexed | 2024-12-13T22:05:32Z |
format | Article |
id | doaj.art-72438d3d445f4f528fb8d1d3a4f5077f |
institution | Directory Open Access Journal |
issn | 0929-6646 |
language | English |
last_indexed | 2024-12-13T22:05:32Z |
publishDate | 2012-03-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of the Formosan Medical Association |
spelling | doaj.art-72438d3d445f4f528fb8d1d3a4f5077f2022-12-21T23:29:51ZengElsevierJournal of the Formosan Medical Association0929-66462012-03-01111317617810.1016/j.jfma.2012.01.009Recurrence of primary aldosteronism after percutaneous ethanol injectionFan-Chi Chang0Kao-Lang Liu1Kuo-How Huang2Vin-Cent Wu3Yen-Hung Lin4Yung-Ming Chen5Kwan-Dun Wu6TAIPAI Study Group7Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Urology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanTaiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, TaiwanAdrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas.http://www.sciencedirect.com/science/article/pii/S0929664612000290adrenal adenomaaldosterone-producing adenomapercutaneous ethanol injectionprimary aldosteronism |
spellingShingle | Fan-Chi Chang Kao-Lang Liu Kuo-How Huang Vin-Cent Wu Yen-Hung Lin Yung-Ming Chen Kwan-Dun Wu TAIPAI Study Group Recurrence of primary aldosteronism after percutaneous ethanol injection Journal of the Formosan Medical Association adrenal adenoma aldosterone-producing adenoma percutaneous ethanol injection primary aldosteronism |
title | Recurrence of primary aldosteronism after percutaneous ethanol injection |
title_full | Recurrence of primary aldosteronism after percutaneous ethanol injection |
title_fullStr | Recurrence of primary aldosteronism after percutaneous ethanol injection |
title_full_unstemmed | Recurrence of primary aldosteronism after percutaneous ethanol injection |
title_short | Recurrence of primary aldosteronism after percutaneous ethanol injection |
title_sort | recurrence of primary aldosteronism after percutaneous ethanol injection |
topic | adrenal adenoma aldosterone-producing adenoma percutaneous ethanol injection primary aldosteronism |
url | http://www.sciencedirect.com/science/article/pii/S0929664612000290 |
work_keys_str_mv | AT fanchichang recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT kaolangliu recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT kuohowhuang recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT vincentwu recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT yenhunglin recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT yungmingchen recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT kwandunwu recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection AT taipaistudygroup recurrenceofprimaryaldosteronismafterpercutaneousethanolinjection |